Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.
Journal: NPJ precision oncology
Published: August 20, 2024
Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors.
Journal: Journal for immunotherapy of cancer
Published: July 29, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial.
Journal: Lancet (London, England)
Published: May 01, 2024
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: March 29, 2024
Pigmented Villonodular Synovitis: A Critical Review.
Journal: Kansas journal of medicine
Published: March 07, 2024
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.
Journal: Cancer
Published: November 08, 2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
Journal: The New England journal of medicine
Published: March 01, 2023
Clinical Impact of Systemic Staging Studies in Secondary Breast Angiosarcoma.
Journal: Surgery in practice and science
Published: December 27, 2021
Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).
Journal: Journal for immunotherapy of cancer
Published: July 01, 2021
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma.
Journal: Molecular cancer therapeutics
Published: June 03, 2020
Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 24, 2018
Last Updated: 09/26/2026